AGC Inc.
Change of Representative Director
Current President Yoshinori Hirai is to become Representative Director and Chairman; Tadayuki Murano is scheduled to assume the position of Representative Director, President & CEO. The effective date is March 30, 2027. Formal approval will be confirmed following the annual general meeting of shareholders in late March 2027 and subsequent board resolution.
Key Figures
- Name of new Representative Director: Tadayuki Murano
- Current Representative Director: Yoshinori Hirai → to become Representative Director and Chairman
- Scheduled effective date: 2027-03-30
AI要約
Appointment of New Representative Director
AGC Inc., based on the nomination committee's recommendation and a board resolution held today, has selected current Senior Executive Officer Tadayuki Murano as the new Representative Director, President & CEO. Yoshinori Hirai will change his position to Representative Director and Chairman effective January 1, 2027. The official assumption of office is scheduled for March 30, 2027, and will be finalized following the annual general meeting of shareholders in late March 2027 and the subsequent board resolution.
Appointee Name, Career Summary and Appointment Timing
The appointee is Tadayuki Murano, who is scheduled to assume the role of Representative Director, President & CEO. Born July 8, 1965, he graduated from Waseda University Faculty of Law. His career includes serving as head of various divisions within the company since 1998; from January 2023 he served as Senior Executive Officer and Head of Corporate Planning, and in January 2024 he became Senior Executive Officer and President of the Life Sciences Company. Mr. Murano currently holds 10,400 shares. The appointment date is scheduled for March 30, 2027.
AGC Inc.
Company overview · Stock price · Financial data · All IR
